Vimarsana
Biggest News Aggregation in the World

Page 10 - Brain Mapping News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brain Mapping. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brain Mapping Today - Breaking & Trending Today

Lawrence Steinman honored for research on ties between EBV, MS | Professor of neurology is also leading development of PAS002 in MS treatment - Vimarsana News

Lawrence Steinman honored for research on ties between EBV, MS | Professor of neurology is also leading development of PAS002 in MS treatment

Lawrence Steinman, who is leading the development of Pasithea's PAS002 for MS, has received the 2023 Pioneer in Medicine Award.

Can Cocaine Addiction Lead to Faster Brain Aging? - Vimarsana News

Can Cocaine Addiction Lead to Faster Brain Aging?

Individuals with cocaine use disorder show greater biological aging in a key area of the brain, findings from a novel study of postmortem brain tissue suggest.

NovAccess Global Inc.: NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress - Vimarsana News

NovAccess Global Inc.: NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress

Dr. Christopher Wheeler, NovAccess Lead Scientist, to Receive Leadership Award for his ContributionsCLEVELAND, OH / ACCESSWIRE / February 3, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company

Ukrainian physicians on the frontline amongst 900 presenters at the 20th Annual World Congress of Society for Brain Mapping and Therapeutics (SBMT) in LA - Vimarsana News

Ukrainian physicians on the frontline amongst 900 presenters at the 20th Annual World Congress of Society for Brain Mapping and Therapeutics (SBMT) in LA

/PRNewswire/ -- Last year, the Society for Brain Mapping and Therapeutics (SBMT) established a task force to help Ukraine with medical humanitarian missions...

MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial Evaluating MN-166 (ibudilast) for Treatment of Recurrent and Newly Diagnosed Glioblastoma - Vimarsana News

MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial Evaluating MN-166 (ibudilast) for Treatment of Recurrent and Newly Diagnosed Glioblastoma

Preliminary results will be presented at the 20th Annual World Congress of the Society for Brain Mapping and TherapeuticsLA JOLLA, Calif., Jan. 12, 2023 -- MediciNova, Inc., a biopharmaceutical... | January 12, 2023